Any 0 3 0 3 O
woman 4 9 4 9 B-gender
who 10 13 10 13 O
has 14 17 14 17 O
completed 18 27 18 27 O
or 28 30 28 30 O
is 31 33 31 33 O
nearing 34 41 34 41 O
completion 42 52 42 52 O
of 53 55 53 55 O
neoadjuvant 56 67 56 67 B-treatment
therapy 68 75 68 75 I-treatment
for 76 79 76 79 O
breast 80 86 80 86 B-cancer
cancer 87 93 87 93 I-cancer
and 94 97 94 97 O
is 98 100 98 100 O
scheduled 101 110 101 110 O
for 111 114 111 114 O
a 115 116 115 116 O
post 117 121 117 121 B-treatment
- 121 122 121 122 I-treatment
NAT 122 125 122 125 I-treatment
breast 126 132 126 132 I-treatment
MRI 133 136 133 136 I-treatment
and 137 140 137 140 O
mammogram 141 150 141 150 B-treatment

Known 0 5 151 156 O
allergic 6 14 157 165 O
reaction 15 23 166 174 O
to 24 26 175 177 O
gadolinium 27 37 178 188 B-allergy_name
; 37 38 188 189 O
patient 39 46 190 197 O
may 47 50 198 201 O
be 51 53 202 204 O
eligible 54 62 205 213 O
if 63 65 214 216 O
the 66 69 217 220 O
referring 70 79 221 230 O
physician 80 89 231 240 O
determines 90 100 241 251 O
that 101 105 252 256 O
the 106 109 257 260 O
MRI 110 113 261 264 B-treatment
is 114 116 265 267 O
medically 117 126 268 277 O
necessary 127 136 278 287 O
and 137 140 288 291 O
if 141 143 292 294 O
the 144 147 295 298 O
patient 148 155 299 306 O
is 156 158 307 309 O
willing 159 166 310 317 O
to 167 169 318 320 O
undergo 170 177 321 328 O
pre 178 181 329 332 B-treatment
- 181 182 332 333 I-treatment
medication 182 192 333 343 I-treatment
for 193 196 344 347 O
contrast 197 205 348 356 O
allergy 206 213 357 364 O

Known 0 5 365 370 O
or 6 8 371 373 O
suspected 9 18 374 383 O
renal 19 24 384 389 B-chronic_disease
impairment 25 35 390 400 I-chronic_disease
. 35 36 400 401 O
Requirements 37 49 402 414 O
for 50 53 415 418 O
GFR 54 57 419 422 O
prior 58 63 423 428 O
to 64 66 429 431 O
MRI 67 70 432 435 O
as 71 73 436 438 O
determined 74 84 439 449 O
by 85 87 450 452 O
local 88 93 453 458 O
site 94 98 459 463 O
standard 99 107 464 472 O
practice 108 116 473 481 O

Male 0 4 482 486 B-gender
patients 5 13 487 495 I-gender

Surgery 0 7 496 503 B-treatment
( 8 9 504 505 O
mastectomy 9 19 505 515 B-treatment
or 20 22 516 518 O
BCT 23 26 519 522 B-treatment
) 26 27 522 523 O
planned 28 35 524 531 O
within 36 42 532 538 O
60 43 45 539 541 B-upper_bound
days 46 50 542 546 I-upper_bound
of 51 53 547 549 O
the 54 57 550 553 O
MRI 58 61 554 557 B-treatment

Women 0 5 558 563 B-gender
who 6 9 564 567 O
have 10 14 568 572 O
a 15 16 573 574 O
contraindication 17 33 575 591 O
to 34 36 592 594 O
the 37 40 595 598 O
intravenous 41 52 599 610 O
use 53 56 611 614 O
of 57 59 615 617 O
iodinated 60 69 618 627 O
contrast 70 78 628 636 O
agent 79 84 637 642 O
( 85 86 643 644 O
i.e. 86 90 644 648 O
, 90 91 648 649 O
allergy 92 99 650 657 O
to 100 102 658 660 O
iodinated 103 112 661 670 O
contrast 113 121 671 679 O
or 122 124 680 682 O
severely 125 133 683 691 O
impaired 134 142 692 700 O
renal 143 148 701 706 O
function 149 157 707 715 O
with 158 162 716 720 O
a 163 164 721 722 O
creatinine 165 175 723 733 B-clinical_variable
level 176 181 734 739 I-clinical_variable
> 182 183 740 741 O
1.3 184 187 742 745 B-lower_bound
or 188 190 746 748 O
eGFR 191 195 749 753 B-clinical_variable
â‰¥45 196 199 754 757 O
) 199 200 757 758 O

Women 0 5 759 764 B-gender
who 6 9 765 768 O
have 10 14 769 773 O
already 15 22 774 781 O
had 23 26 782 785 O
their 27 32 786 791 O
standard 33 41 792 800 O
of 42 44 801 803 O
care 45 49 804 808 O
post 50 54 809 813 O
- 54 55 813 814 O
NAT 55 58 814 817 O
mammogram 59 68 818 827 O
and/or 69 75 828 834 O
breast 76 82 835 841 O
MRI 83 86 842 845 O

